---
title: "Theranositics|DAB2+巨噬细胞协助FAP+成纤维细胞塑造肿瘤屏障，诱导肝癌免疫排斥"
date: 2024-08-16T06:37:46Z
draft: ["false"]
tags: [
  "fetched",
  "医学僧的科研日记"
]
categories: ["Acdemic"]
---
Theranositics|DAB2+巨噬细胞协助FAP+成纤维细胞塑造肿瘤屏障，诱导肝癌免疫排斥 by 医学僧的科研日记
------
<div><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><mp-common-profile data-pluginname="mpprofile" data-id="MzkxMDM0MzI2Nw==" data-headimg="http://mmbiz.qpic.cn/mmbiz_png/uhZO1OUaYWjib2ZcqlVmzlaicQdfs7xotqpueDAAAeYcnySknOB8ziaGyHnzw6I5aQ71sXO5ebGWHWw16WaegIpfQ/0?wx_fmt=png" data-nickname="单细胞技术与肿瘤液体活检中心" data-alias="" data-signature="武汉大学中南医院单细胞技术与肿瘤液体活检中心（Center for Single-Cell Omics and Tumor Liquid Biopsy，SCTB）成立于2021年，是集科学研究、临床转化、人才培养为一体的综合科技创新平台。" data-from="0" data-is_biz_ban="0"></mp-common-profile></section><section><span><span><span></span></span></span></section><section><span><span><span>肝癌是全球癌症相关死亡的主要原因之一。肝细胞癌（HCC）是最常见的肝癌类型，其次是肝内胆管癌（ICC），两者合计占95%以上，另外包括少部分混合型肝癌（CHC）和继发性肝癌（</span><span>SLC</span><span>）。免疫治疗在肝癌的一线治疗中已被广泛考虑。然而，免疫疗法仅对20-30%的患者有效。改善免疫治疗反应的途径在很大程度上受到肝癌微环境异质性的限制。癌症相关成纤维细胞（CAFs）是肿瘤微环境中最为广泛存在的基质细胞，参与肿瘤免疫屏障的形成。深入了解CAF异质性和细胞间通讯对于提高免疫治疗效果和改善肝癌患者临床结局至关重要。</span></span><p></p></span></section><section><span>   </span><span>近日，中心在 <em><strong>Theranostics </strong></em>期刊上发表了名为：DAB2+ macrophages support FAP+ fibroblasts in shaping tumor barrier and inducing poor clinical outcomesin liver cancer的研究成果。通过整合超过120万个细胞的235个肝癌单细胞测序样本，研究者发现成纤维细胞在HCC和ICC中特异性增加。FAP+成纤维细胞被确定为CAFs的优势亚型，主要参与细胞外基质塑造和促血管生成。这些CAFs在HCC的肿瘤边界富集，但在ICC内弥漫性分布。DAB2+和SPP1+ TAMs通过TGF-β、PDGF、ADM等信号增强FAP+ CAFs的功能。值得注意的是，DAB2+ TAMs与FAP+ CAFs的细胞通讯促进了HCC边界免疫屏障的形成，并与HCC患者较差的预后和免疫治疗无应答相关。破坏这种通讯或抑制FAP+ CAFs的功能可能是一种潜在的免疫治疗增敏策略。</span><span></span></section><p>  <img data-imgfileid="100028063" data-ratio="0.4981481481481482" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVJx8N3HGArNV3oibRCUd0sXRYicxIF0icPOOyvsH2sGTgeYUpIVH3hibtfw/640?wx_fmt=png&amp;from=appmsg&amp;wxfrom=13" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVJx8N3HGArNV3oibRCUd0sXRYicxIF0icPOOyvsH2sGTgeYUpIVH3hibtfw/640?wx_fmt=png&amp;from=appmsg&amp;wxfrom=13"></p><p><span>研究示意图</span></p></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>1、</strong><em><strong><span>FAP+ </span></strong></em><strong><span>CAFs在肝癌中显著增加</span></strong></section></section><section><br></section></section><section><br></section></section><section><span><span><span>在单细胞肝癌发现队列中，总计156例样本，包括癌旁（AL），外周血（PB），肝细胞癌（HCC），肝内胆管癌（ICC），混合型肝癌（CHC）和继发性肝癌（SLC），作者发现成纤维细胞在HCC和ICC中特异性升高，且这种升高主要是由FAP+ CAFs带来的。FAP+ CAFs的功能集中在促血管生成和胶原纤维形成方面。接下来，作者进一步在包含79例样本的单细胞验证队列、基于组织的细胞</span><span>反卷积</span><span>推算及临床免疫组化队列中验证了FAP+ CAFs在HCC和ICC中的升高，且ICC升高更为显著</span></span><span>。</span></span></section><section><span><span><img data-backh="328" data-backw="540" data-imgfileid="100028061" data-ratio="0.6074074074074074" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVtYD03BYQ5pd6O2nWNUkDJH86kdGhTKWA2ZGmG922ttjTNKlUdP2yFg/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVtYD03BYQ5pd6O2nWNUkDJH86kdGhTKWA2ZGmG922ttjTNKlUdP2yFg/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>2、</strong><em><strong><span>FAP</span></strong></em><strong><span>+ CAFs预示患者更差的生存结局</span></strong></section></section><section><br></section></section><section><br></section></section><p><span><span>研究者通过单细胞队列、TCGA队列及额外的4个GEO队列（GSE14520, GSE40873, GSE76427, GSE116174）都证实了FAP+ CAFs的高浸润预示患者更差的总体生存。且</span><span>淋巴结转移</span><span>、远端转移及晚期患者具有更高的FAP+ CAFs浸润</span></span><span>。</span></p><section><span><img data-backh="485" data-backw="538" data-imgfileid="100028062" data-ratio="0.9018518518518519" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVCGup8DeGXT3LkAKha8GXktHx7zRBGhft9CTaKpDPUOmUOelA80YQgQ/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVCGup8DeGXT3LkAKha8GXktHx7zRBGhft9CTaKpDPUOmUOelA80YQgQ/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></section><section><span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>3、</strong><em><strong><span>FAP</span></strong></em><strong><span>+ CAFs的空间分布异质性</span></strong></section></section><section><br></section></section><section><br></section></section><p><span>接下来，研究者也在空间转录组样本中验证了FAP+ CAFs在肿瘤样本中的增加。并进一步探索了FAP+ CAFs在HCC和ICC中的空间分布差异，其中FAP+ CAFs更偏好于分布在HCC的肿瘤边界区域，而散在分布于ICC肿瘤区域。这可能部分解释了为什么FAP+ CAFs在HCC中相比于ICC肿瘤组织单细胞比例相对更少，因为它们多集中于肿瘤侵袭前沿</span><span>。</span></p><section><span><img data-backh="295" data-backw="538" data-imgfileid="100028060" data-ratio="0.5472222222222223" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFV1LtlmJWHHVkXBibiaA7icPtqGlp51580RAeBFSeEfgZhm07zDtbAbWfEw/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFV1LtlmJWHHVkXBibiaA7icPtqGlp51580RAeBFSeEfgZhm07zDtbAbWfEw/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></section><section><span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>4、</strong><em><strong><span>FAP</span></strong></em><strong><span>+ CAFs与TAMs存在空间共定位</span></strong></section></section><section><br></section></section><section><strong><br></strong></section></section><p><span>通过进一步细胞浸润相关性及空间共定位分析，研究者发现在HCC中FAP+ CAFs与DAB2+ TAMs具有最强的共定位潜力，且集中分布于肿瘤边界，而在ICC中FAP+ CAFs则与SPP1+ TAMs具有最强的共定位潜力，在肿瘤边界没有富集偏好性（集中分布于ICC肿瘤区域）。这一结论进一步通过多色免疫荧光证实</span><span>。</span></p><section><span><img data-backh="425" data-backw="538" data-imgfileid="100028064" data-ratio="0.7907407407407407" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVk5bNrS7oOz0cS79FWtiakibHfTEEK6UZicTC2br3emcZu3oO6tysxibJkA/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVk5bNrS7oOz0cS79FWtiakibHfTEEK6UZicTC2br3emcZu3oO6tysxibJkA/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>5、</strong><strong><span>HCC边界纤维屏障阻止免疫细胞浸润</span></strong></section></section><section><br></section></section><section><br></section></section><p><span>FAP+ CAFs与DAB2+ TAMs在HCC边界的积聚可能限制了免疫细胞迁移到肿瘤核心发挥抗肿瘤作用，大量免疫细胞被排斥在边界之外，或被限制在纤维屏障之中</span><span><span>。</span></span></p><section><span><span><img data-backh="303" data-backw="538" data-imgfileid="100028067" data-ratio="0.5638888888888889" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVm5gs7fVyS5c18hcYeALr9yF3FrF0nAGGF5icQiadg7cPicU9EwUHVuM0w/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVm5gs7fVyS5c18hcYeALr9yF3FrF0nAGGF5icQiadg7cPicU9EwUHVuM0w/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>6、</strong><em><strong><span>DAB2</span></strong></em><strong><span>+ TAMs强化<em>FAP</em>+ CAFs基质塑造功能</span></strong></section></section><section><br></section></section><section><br></section></section><p><span>通过配受体交流分析，研究者发现DAB2+ TAMs可能通过PDGF信号作用于FAP+ CAFs，促进其胶原分泌，增强其对边界纤维屏障的塑造</span><span>。</span></p><section><span><img data-backh="372" data-backw="538" data-imgfileid="100028069" data-ratio="0.6907407407407408" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFV1OibKxiaibiaomBXFy3ibHpDAUMyBxStibNUPbUrvU6Xdezlkc2pCnazQVIQ/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFV1OibKxiaibiaomBXFy3ibHpDAUMyBxStibNUPbUrvU6Xdezlkc2pCnazQVIQ/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></section><section><span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>7、</strong><em><strong><span>FAP</span></strong></em><strong><span>+ CAFs和<em>DAB2</em>+ TAMs的泛癌分析</span></strong></section></section><section><br></section></section><section><br></section></section><p><span>通过整合305例样本的泛癌单细胞队列，发现FAP+ CAFs和DAB2+ TAMs可在多种癌症中鉴定出来，具有不同的浸润丰度。在空间层面，肿瘤边界区域具有明显FAP+ CAFs和DAB2+ TAMs分布的患者通常对免疫治疗耐受，且免疫细胞无法进入肿瘤核心；相反，边界区域无明显FAP+ CAFs和DAB2+ TAMs分布的患者通常对免疫治疗敏感，免疫细胞可进入肿瘤核心。此外，作者还整合了30例接受免疫治疗的单细胞测序样本进行分析，无响应组具有更高的FAP+ CAFs和DAB2+ TAMs浸润</span><span>。</span></p><section><span><img data-backh="315" data-backw="538" data-imgfileid="100028065" data-ratio="0.5861111111111111" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVa3xpyCYtoaN58QAxjAF72XibyjsXdibcpZtQZ2UiaRM49DqeiaCLKWR5zQ/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVa3xpyCYtoaN58QAxjAF72XibyjsXdibcpZtQZ2UiaRM49DqeiaCLKWR5zQ/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></section><section><span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>8、</strong><em><strong><span>FAP</span></strong></em><strong><span>+ CAFs和<em>DAB2</em>+ TAMs的临床队列分析</span></strong></section></section><section><br></section></section><section><br></section></section><p><span><span>最后，为探究这两种细胞类型对患者生存风险的影响，研究者对90例HCC肿瘤边界样本进行了</span><span>免疫组化</span><span>分析，高的FAP和DAB2染色光密度可预示患者更差的总体生存。且高的FAP和DAB2染色光密度与更大的肿瘤尺寸和更高的血清AFP浓度呈正相关。这些结果表明，FAP和DAB2可能是潜在的临床风险预测指标</span></span><span>。</span></p><section><span><img data-imgfileid="100028066" data-ratio="0.7129629629629629" data-s="300,640" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVXU4Boh0nEEseVNGnQ1PmHXEakHDVmNWaL92LKq5iaX5JBZelu7soYSA/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="1080" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWiayQGVibkv5jODBaU3kDqBFVXU4Boh0nEEseVNGnQ1PmHXEakHDVmNWaL92LKq5iaX5JBZelu7soYSA/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></span></section><section><span></span></section></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><section><strong>9、总结</strong></section></section><section><br></section></section><section><br></section></section><p><span>本研究发现FAP+ CAFs是一种保守的癌症相关成纤维细胞亚型，在不同的肝癌类型中存在功能和空间分布异质性，且与患者更差的生存显著相关。肿瘤相关巨噬细胞在增强FAP+ CAFs的功能中发挥重要作用，特别是通过DAB2+ TAMs与FAP+ CAFs的互作促进HCC免疫屏障的塑造。</span><span>靶向DAB2+ TAMs、FAP+ CAFs及其通讯分子的治疗方法有望显著提高免疫治疗疗效并改善患者预后。</span><span></span></p></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><section><section><section><strong>参考文献</strong></section></section><section><br></section></section></section><section><p><span>DAB2+ macrophages support FAP+ fibroblasts in shaping tumor barrier and inducing poor clinical outcomes in liver cancer. Theranostics. 2024. 14 (12): 4822 - 4843.</span></p></section></section></section></section></section><section data-class="_mbEditor"><section data-class="_mbEditor"><img data-ratio="1" data-w="1080" data-imgfileid="100028068" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWgHfrIxtE98gqgzDBtXRkFcOuCTRiazbqLT1FEM3WqxqV2pUmLKWFmVyLxwT8YanfzI9NdHicObswpQ/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWgHfrIxtE98gqgzDBtXRkFcOuCTRiazbqLT1FEM3WqxqV2pUmLKWFmVyLxwT8YanfzI9NdHicObswpQ/640?wx_fmt=other&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></section><p><span>审核</span><span>：</span><span>龙飞</span></p></section><section data-class="_mbEditor"><section data-class="_mbEditor"><section><section><section><img data-imgfileid="100028070" data-ratio="0.2081447963800905" data-src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWhaSNz8b50BDkTRDOtFcibBJcFnicNcYVGia15HyHVpv0C2bQicGrO7VRo3IdjiadAQJ8icIcTvGfrmhW4w/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp" data-type="png" data-w="663" src="https://mmbiz.qpic.cn/sz_mmbiz_png/uhZO1OUaYWhaSNz8b50BDkTRDOtFcibBJcFnicNcYVGia15HyHVpv0C2bQicGrO7VRo3IdjiadAQJ8icIcTvGfrmhW4w/640?wx_fmt=other&amp;from=appmsg&amp;wxfrom=5&amp;wx_lazy=1&amp;wx_co=1&amp;tp=webp"></section></section></section></section></section><p><br></p><p><mp-style-type data-value="10000"></mp-style-type></p></div>  
<hr>
<a href="https://mp.weixin.qq.com/s/KRno0J_u_WipVoZTPl6Reg",target="_blank" rel="noopener noreferrer">原文链接</a>
